Septal defects

Q17_SEPTA_DEFEC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q21.0, Q21.10, Q21.11, Q21.12, Q21.13, Q21.18, Q21.19, Q21.88, Q21.9 Hospital discharge: ICD-9 — 7454E\|7454X\|7454A\|7455A\|7456X\|7456A\|7458X\|7459X Hospital discharge: excluded ICD-10 — Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875 Hospital discharge: excluded ICD-9 — 758\|7595\|75683 Cause of death: ICD-10 — Q21.0, Q21.10, Q21.11, Q21.12, Q21.13, Q21.18, Q21.19, Q21.88, Q21.9 Cause of death: ICD-9 — 7454E\|7454X\|7454A\|7455A\|7456X\|7456A\|7458X\|7459X Cause of death: excluded ICD-10 — Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875 Cause of death: excluded ICD-9 — 758\|7595\|75683 2 out of 7 registries used, show all original rules.	2525
4. Check minimum number of events None	2525
5. Include endpoints None	2525
6. Filter based on genotype QC (FinnGen only)	2525

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF7

NAME	Q17_SEPTA_DEFEC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q2100\|Q2108\|Q2109\|Q2110\|Q2111\|Q2112\|Q2113\|Q2118\|Q2119\|Q2188\|Q219
HD_ICD_9	7454E\|7454X\|7454A\|7455A\|7456X\|7456A\|7458X\|7459X
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL	Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875
HD_ICD_9_EXCL	758\|7595\|75683
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q2100\|Q2108\|Q2109\|Q2110\|Q2111\|Q2112\|Q2113\|Q2118\|Q2119\|Q2188\|Q219
COD_ICD_9	7454E\|7454X\|7454A\|7455A\|7456X\|7456A\|7458X\|7459X
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL	Q90\|Q91\|Q92\|Q93\|Q96\|Q8780\|Q8781\|Q8782\|Q8783\|Q8784\|Q8786\|Q8788\|Q85\|Q796\|Q874\|Q875
COD_ICD_9_EXCL	758\|7595\|75683
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Septal defects based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	37758	20128	17561
Only index persons	24425	13039	11386
Unadjusted period prevalence (%)
Whole population	0.54	0.58	0.49
Only index persons	0.46	0.48	0.43
Median age at first event (years)
Whole population	0.53	0.50	0.42
Only index persons	3.90	4.73	2.96

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2525	1500	1025
Unadjusted period prevalence (%)	0.49	0.51	0.45
Median age at first event (years)	38.10	34.81	42.91

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2271: Matched controls
22141

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

+∞

323.0

323

FFC22

NOMESCO Finland

Percutaneous transluminal closure of ostium secundum type ASD

733.6

323.0

324

Q21.10

ICD-10 Finland

Persistent ostium secundum

5116.1

323.0

747

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

26.6

323.0

865

500

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

+∞

323.0

314

Q21.08

ICD-10 Finland

Other specifed ventricular septal defect

+∞

323.0

458

Q21.19

ICD-10 Finland

Atrial septal defect NOS

4395.1

323.0

388

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

7.1

323.0

1028

2295

Q21.11

ICD-10 Finland

Paten or persistent foramen ovale

4640.7

323.0

699

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

7.1

277.1

801

1582

XF620

NOMESCO Finland

Examination of circulation with color method

179.1

235.8

246

B01AA03

ATC

warfarin; systemic

5.5

184.9

632

1439

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

12.2

172.0

330

305

XF400

NOMESCO Finland

ECG with 12 standard connections

4.4

157.3

695

2030

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

7.5

155.6

400

613

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

20.9

153.3

234

121

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

326.8

153.3

155

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

147.1

1168

5451

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

8.7

135.0

310

393

Congenital heart failure surgery

273.5

129.3

132

7455A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect

+∞

119.8

115

XF404

NOMESCO Finland

Ambulatory ECG

5.3

118.9

401

856

201

Kela drug reimbursment

Chronic cardiac insufficiency

10.0

118.8

250

270

Q21.9

ICD-10 Finland

Congenital malformation of cardiac septum, unspecified

+∞

110.3

106

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

5.0

103.7

370

832

Q21.0

ICD-10 Finland

Ventricular septal defect

502.1

99.3

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

18.7

97.6

154

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

321.4

92.7

FFC42

NOMESCO Finland

Percutaneous closure of patent foramen ovale

901.2

90.6

I48

ICD-10 Finland

Atrial fibrillation and flutter

3.4

83.2

463

1539

Q21.18

ICD-10 Finland

Other spedified atrial septal defect

+∞

83.1

FM2CE

NOMESCO Finland

7.0

81.3

212

319

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.1

74.1

465

1674

C03CA01

ATC

furosemide; systemic

2.9

72.9

530

2103

5205

FHL

ASD blockage, secondary defect

712.6

71.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.4

70.9

280

685

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.1

69.8

457

1687

C01AA05

ATC

digoxin; systemic

5.7

67.8

208

386

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

6.6

67.3

182

287

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

65.7

785

4081

PA2AE

NOMESCO Finland

Ultrasound examination of brain artery

323.0

64.1

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

11.9

64.1

121

104

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

317.8

63.1

Q25.0

ICD-10 Finland

Patent ductus arteriosus

16.4

59.1

7454A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM NUD]

+∞

59.1

XF402

NOMESCO Finland

ECG with work load test

3.5

58.7

300

914

Catheterization and pressure measurement of the right side of the heart

44.6

57.2

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

56.9

329

1100

Q25.1

ICD-10 Finland

Coarctation of aorta

23.6

56.7

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

53.9

858

4972

7454B

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Ventricular septal defect[DEFECTUS SEPTI VENTRICULORUM SIMPLEX]

+∞

53.9

AA1AD

NOMESCO Finland

CT of head and brain

2.5

53.5

503

2271

TFP20

NOMESCO Finland

Cardiodefibrillation

4.5

53.2

203

476

C07AB07

ATC

bisoprolol; oral

2.1

52.6

827

4754

C03DA01

ATC

spironolactone; oral

3.6

52.4

255

744

Catheterization and pressure measurement of the left side of the heart

14.2

51.9

5253

FHL

Cardiac lung machine

38.3

50.9

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

50.0

929

5680

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.0

49.2

166

342

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

4.4

48.2

188

449

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

48.1

615

3205

WX892

NOMESCO Finland

Monitored bed care

3.4

48.1

259

817

B01AC04

ATC

clopidogrel; oral

3.0

47.6

299

1053

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

6.0

47.2

137

236

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

47.1

269

885

Q22.1

ICD-10 Finland

Congenital pulmonary valve stenosis

37.5

46.8

XA800

NOMESCO Finland

Neuropsychological investigation

3.5

46.5

236

710

APK

ASD closure

+∞

45.5

FFC50

NOMESCO Finland

Closure of ostium secundum type ASD using patch

+∞

45.5

XFE00

NOMESCO Finland

Epicardial ultrasonography

8.4

45.3

103

125

Q23.11

ICD-10 Finland

Bicuspid aortic valve

12.6

43.9

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.6

43.5

132

240

Q21.1

ICD-10 Finland

Atrial septal defect

+∞

43.5

Q21.20

ICD-10 Finland

Atrial septal defect of primum type

424.8

42.9

207

Kela drug reimbursment

Chronic arrhythmias

3.0

41.8

270

964

APJ

PFO closure

+∞

41.4

5207

FHL

VSD closure

+∞

41.4

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

18.1

41.4

XF600

NOMESCO Finland

Bloodpressure measurement

3.0

41.3

260

913

WX872

NOMESCO Finland

Intensive care

4.3

40.5

157

372

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

40.3

369

1618

Q20.3

ICD-10 Finland

Discordant ventriculoarterial connection

44.3

39.7

AF1

Surgery of congenital heart defect

203.4

39.6

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.1

38.3

157

393

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

10.9

38.0

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

37.8

217

711

FHB50

NOMESCO Finland

Transatrial closure of VSD using patch

132.2

37.4

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.4

37.3

142

331

XF622

NOMESCO Finland

Measurement of minute volume of heart

17.8

36.2

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

5.9

35.6

103

177

7456A

ICD-9 Finland

Bulbus cordis anomalies and anomalies of cardiac septal closure, Endocardial cushion defects[DEFECTUS SEPTI ATRIORUM NUD]

+∞

35.2

TFC99

NOMESCO Finland

Catheterisation of heart with other procedure

11.8

34.8

ZXE00

NOMESCO Finland

One hour or less

1.8

34.0

927

6229

Q20.1

ICD-10 Finland

Double outlet right ventricle

173.2

33.5

Z2221

NOMESCO Finland

Medical doctor

1.9

33.1

669

4066

Q21.12

ICD-10 Finland

Defective sinus venosus

+∞

33.1

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

33.0

501

2740

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

7.6

32.9

105

XF640

NOMESCO Finland

6.2

32.3

144

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

32.2

458

2435

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.3

32.2

176

557

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

15.2

31.2

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

31.0

247

995

K78

ICPC

Atrial fibrillation/flutter

3.5

31.0

152

443

R4150

NOMESCO Finland

Neuropsychological rehabilitation

10.0

30.6

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.0

30.0

100

203

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

15.1

29.9

Q21.21

ICD-10 Finland

Atrioventricular duct

49.4

29.1

I34.1

ICD-10 Finland

Mitral (valve) prolapse

5.5

28.8

158

B01AB05

ATC

enoxaparin; parenteral

1.9

28.6

529

3089

R4110

NOMESCO Finland

Physiotherapy

1.8

28.6

604

3694

5255

FHL

Deep hypothermia (<20 °) with cardiopulmonary resuscitation

+∞

27.9

I49.5

ICD-10 Finland

Sick sinus syndrome

5.3

27.4

160

WX882

NOMESCO Finland

High dependency care

2.9

27.1

176

626

WX402

NOMESCO Finland

General anaesthesia

1.9

26.4

434

2423

C01BD01

ATC

amiodarone; systemic

5.8

26.3

131

C10AA05

ATC

atorvastatin; oral

1.8

25.6

565

3485

K90

ICPC

Stroke/cerebrovascular accident

5.7

25.4

129

R4120

NOMESCO Finland

Occupational therapy

2.6

25.3

195

771

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.4

25.2

224

956

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

3.4

24.1

123

370

Q21.30

ICD-10 Finland

Tetralogy of Fallot

19.8

24.0

ZXD05

NOMESCO Finland

Urgent procedure

1.7

23.7

642

4193

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

5.4

23.5

134

Q26.3

ICD-10 Finland

Partial anomalous pulmonary venous connection

85.5

23.4

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

6.6

23.0

AA5PD

NOMESCO Finland

CT examination of brain pefusion

11.2

22.8

GAE10

NOMESCO Finland

Closure of previous incision of chest wall

11.6

22.6

C07AA07

ATC

sotalol; systemic

4.6

22.4

176

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

39.5

22.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

22.4

253

1207

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

22.3

193

810

I37.0

ICD-10 Finland

Pulmonary valve stenosis

44.3

22.1

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.9

22.1

104

C09AA05

ATC

ramipril; oral

1.9

22.0

359

1986

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

4.6

21.9

171

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

21.9

367

2052

Q26.1

ICD-10 Finland

Persistent left superior vena cava

42.7

21.2

I50.0

ICD-10 Finland

Congestive heart failure

3.3

21.0

109

333

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

21.0

457

2784

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

5.4

21.0

119

74663

ICD-8 Finland

Congenital anomalies of heart, Stenosis valvulae pulmonalis

75.6

20.5

Z3231

NOMESCO Finland

Registered nurse

1.6

20.3

664

4528

Q21.29

ICD-10 Finland

Atrioventricular septal defect UNS

+∞

19.6

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

15.1

19.4

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.3

19.3

188

837

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

24.2

19.3

AP3

Catheterization of the right and left side of the heart

21.2

19.2

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.5

18.9

258

R06.0

ICD-10 Finland

Dyspnoea

1.7

18.7

446

2779

R42

ICD-10 Finland

Dizziness and giddiness

1.8

18.7

369

2170

I37.1

ICD-10 Finland

Pulmonary valve insufficiency

33.8

18.7

Q21.80

ICD-10 Finland

Communication from left ventricle to right atrium

+∞

18.6

74646

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium primum

+∞

18.6

FFC32

NOMESCO Finland

Percutaneous transluminal closure of sinus venosus type ASD

+∞

18.6

Q20.48

ICD-10 Finland

Single ventricle

27.4

18.5

Q23.0

ICD-10 Finland

Congenital stenosis of aortic valve

13.2

18.4

AP2

Catheterization of the right side of the heart

18.4

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

5.0

18.3

117

C07AB02

ATC

metoprolol; systemic

1.9

18.3

307

1708

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

3.9

18.1

196

I63

ICD-10 Finland

Cerebral infarction

10.8

17.9

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

3.5

17.8

239

G04BE03

ATC

sildenafil; oral

5.8

17.7

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

17.6

217

1073

7471A

ICD-9 Finland

Other congenital anomalies of circulatory system, Coarctation of aorta[COARCTATIO AORTAE]

93.4

17.4

90492

NOMESCO Finland

93.4

17.4

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

7.2

17.4

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.2

17.1

285

602

Kela drug reimbursment

Children's severe malnutrition

3.8

16.9

184

J01CA04

ATC

amoxicillin; systemic

1.6

16.9

1873

16515

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

9.1

16.8

FXA10

NOMESCO Finland

Total cardiopulmonary bypass in deep hypothermia at concurrent surgical procedure

13.0

16.7

TFP34

NOMESCO Finland

Electrophysiological investigation

3.6

16.7

211

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.2

16.6

286

FFC40

NOMESCO Finland

Closure of Patent Foramen Ovale

+∞

16.5

Q90.9

ICD-10 Finland

Down syndrome, unspecified

27.0

16.3

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

461

910

5.84

221.89

3.9

6.7

94.4

92.4

0.97

437

879

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1041

3889

3.76

219.14

4.9

3.4

ng/l

1120.6

1214.5

0.32

929

3253

(3032080) INR in Blood by Coagulation assay

1382

6284

3.55

212.39

15.0

7.6

inr

1.5

1.2

15.80

374

1866

(3018677) aPTT in Platelet poor plasma by Coagulation assay

843

2872

3.81

201.10

3.4

3.7

31.2

30.1

4.04

829

2806

(4306422)

251

313

8.60

185.11

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

246

305

8.64

182.23

1.1

1.2

116.6

111.9

1.06

239

283

(3036489) Thrombin time

406

968

4.70

154.49

2.9

4.8

21.9

22.1

0.29

334

888

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

229

340

7.15

144.57

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

422

1147

4.12

134.45

4.0

3.7

ng/l

188.7

183.3

0.09

377

1031

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

215

342

6.63

126.92

1.3

u/ml

3.9

5.0

0.46

162

(3033658) Prothrombin time (PT) actual/Normal

1000

4911

2.64

115.08

5.3

5.4

81.0

90.9

26.01

984

4802

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

199

342

6.09

108.53

1.3

u/ml

3.2

3.7

0.14

125

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

319

843

4.09

104.47

3.0

5.0

157.3

169.6

1.98

314

819

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

908

4552

2.49

96.58

2.4

2.6

—

(4268621)

154

236

6.73

93.84

2.5

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

1040

5833

2.27

82.63

2.5

2.7

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

895

4872

2.24

74.83

2.7

2.2

u/l

232.6

239.8

0.08

858

4624

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1355

8693

2.13

74.13

4.0

4.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

635

3036

2.40

71.63

4.2

3.5

ng/l

1192.9

542.2

2.10

498

2100

(3012095) Magnesium [Moles/volume] in Serum or Plasma

603

2934

2.33

64.52

5.9

6.5

mmol/l

0.8

2.10

578

2774

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

9.45

64.46

1.0

1.1

99.1

91.7

0.97

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

100

8.47

63.66

1.2

u/ml

21.6

10.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1581

11125

2.05

62.98

7.1

5.7

mmol/l

6.2

6.5

8.60

1506

10352

(3022217) INR in Platelet poor plasma by Coagulation assay

401

1662

2.62

60.55

44.3

20.8

inr

1.9

1.2

5.92

235

(3034426) Prothrombin time (PT)

9.64

60.43

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

114

7.61

59.58

1.1

ratio

1.1

0.81

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

958

5754

2.01

58.61

4.3

3.2

ng/l

45.2

47.5

0.08

655

3491

(3044889) 12 lead EKG panel

1644

11912

2.01

57.96

4.7

3.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

21.44

53.91

2.4

3.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

249

850

3.07

53.87

4.3

5.8

g/l

3.0

3.2

1.77

241

820

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

10.54

51.99

4.7

8.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

10.98

50.72

3.9

8.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

418

1916

2.36

50.16

8.0

11.4

mmol/l

7.0

7.5

0.92

411

1857

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

175

517

3.48

47.84

9.8

8.1

u/ml

0.4

0.3

1.00

128

291

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1221

8630

1.74

39.92

10.6

8.6

mmol/l

1.2

4.94

1146

7960

(3003458) Phosphate [Moles/volume] in Serum or Plasma

537

2982

1.97

38.42

7.4

8.8

mmol/l

1.2

0.70

517

2806

(3019550) Sodium [Moles/volume] in Serum or Plasma

2287

19780

2.41

36.93

20.1

14.2

mmol/l

139.5

139.6

1.69

2261

19244

(3023103) Potassium [Moles/volume] in Serum or Plasma

2288

19828

2.39

36.14

20.1

14.3

mmol/l

4.0

1.72

2259

19243

(3013512) EKG study

703

4383

1.79

34.45

5.0

3.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

270

1201

2.34

34.04

2.2

2.3

ug/l

14.6

7.1

4.28

238

1059

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1271

9355

1.66

33.58

9.7

8.7

mmol/l

1.2

3.49

1063

8144

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

7.54

32.66

1.2

1.1

—

(42870588) Differential panel, method unspecified - Blood

1070

7572

1.66

32.63

6.2

7.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

337

1733

2.04

29.35

12.6

9.4

kpa

5.3

5.1

1.97

328

1664

(3027801) Oxygen [Partial pressure] in Arterial blood

337

1733

2.04

29.35

12.6

9.4

kpa

13.4

12.9

0.81

328

1667

(3003396) Base excess in Arterial blood by calculation

335

1732

2.03

28.71

12.7

9.4

mmol/l

1.0

0.9

0.08

281

1364

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

200

853

2.41

27.59

17.5

13.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

392

2168

1.91

27.57

9.6

8.2

mmol/l

1.8

1.0

6.66

321

1578

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

6.78

27.23

1.2

—

(3016502) Oxygen saturation in Arterial blood

303

1548

2.04

26.75

13.5

10.0

96.0

95.4

0.75

295

1496

(3009343) pH of Capillary blood

394

2203

1.89

26.74

9.6

8.2

7.4

0.20

153

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

395

2214

1.88

26.60

9.6

8.2

kpa

5.2

5.1

2.77

387

2114

(3014007) Fractional oxyhemoglobin in Arterial blood

220

999

2.26

26.25

15.0

11.6

94.6

94.1

0.44

220

994

(3003694) ABO and Rh group [Type] in Blood

878

6165

1.60

26.02

1.5

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2286

20292

2.09

25.85

16.5

12.5

mg/l

22.9

22.4

0.26

1851

15350

(3000991) Gas panel - Venous blood

408

2331

1.85

25.81

12.0

10.3

—

(44806071)

10.64

25.35

1.0

—

(3001604) Monocytes [#/volume] in Blood

1374

10746

1.55

25.03

6.4

7.2

e9/l

0.6

1.53

1174

9203

(3006315) Basophils [#/volume] in Blood

1373

10768

1.54

24.46

6.4

7.2

e9/l

0.0

0.51

1178

9228

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2320

20781

2.15

24.39

17.8

13.5

umol/l

70.7

70.8

0.03

2320

20773

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

423

2500

1.79

23.79

2.9

21.5

22.9

1.41

381

2211

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1188

9083

1.53

23.40

7.2

6.6

umol/l

16.5

13.9

2.63

1103

8564

(3024928) Oxygen saturation in Venous blood

121

439

2.78

23.23

5.3

11.1

—

(3022313) Gas panel - Capillary blood

329

1813

1.89

23.16

9.8

8.5

—

(3019198) Lymphocytes [#/volume] in Blood

1396

11077

1.52

22.89

6.4

7.2

e9/l

1.9

2.1

3.98

1210

9700

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

627

4161

1.63

22.88

2.8

2.5

mg/l

1.2

0.04

467

3105

(3013115) Eosinophils [#/volume] in Blood

1396

11125

1.51

22.06

6.8

7.7

e9/l

0.2

1.42

1212

9700

(3022096) Basophils/100 leukocytes in Blood

1270

9937

1.50

21.84

6.7

7.5

0.7

0.13

1217

9399

(3004789) Transferrin [Mass/volume] in Serum or Plasma

439

2692

1.72

21.53

2.8

2.7

g/l

2.5

2.4

0.88

409

2514

(3019069) Monocytes/100 leukocytes in Blood

1303

10278

1.50

21.35

6.9

7.6

8.7

8.4

2.65

1252

9743

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

296

1619

1.89

21.24

3.2

3.0

—

(3021589) Normoblasts [#/volume] in Blood

1253

9818

1.49

21.13

10.1

10.0

e9/l

0.0

0.37

1005

7871

(3002173) Hemoglobin [Mass/volume] in Arterial blood

268

1425

1.94

20.93

12.1

9.9

g/l

122.2

122.6

0.11

257

1378

(3022948) Iron [Moles/volume] in Serum or Plasma

469

2954

1.68

20.76

2.9

2.7

umol/l

12.7

13.7

2.03

438

2768

(3006504) Eosinophils/100 leukocytes in Blood

1292

10213

1.49

20.68

6.7

7.4

2.9

3.0

0.75

1237

9636

(40761511) CBC panel - Blood by Automated count

2327

21062

2.05

20.61

16.4

11.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

994

7502

1.49

19.74

5.7

5.8

g/l

36.2

36.4

0.38

929

7024

(3023368) Bacteria identified in Blood by Culture

645

4449

1.56

19.53

4.1

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

1327

10645

1.46

19.06

6.7

7.4

29.3

31.2

7.56

1269

10067

(3018738) Hemoglobin F/Hemoglobin.total in Blood

4.96

18.90

3.2

3.9

4.8

3.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

129

4.01

18.35

1.2

—

(3012544) pH of Venous blood

412

2595

1.66

18.02

6.4

8.0

7.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

433

2769

1.64

17.83

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

297

1714

1.79

17.82

13.8

10.0

mmol/l

1.4

0.12

285

1613

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

6.74

17.74

1.5

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

236

1283

1.88

17.15

3.7

4.1

mmol/l

1.2

0.85

221

1116

(3018010) Neutrophils/100 leukocytes in Blood

1298

10492

1.43

17.13

6.5

7.2

55.6

54.0

4.80

1247

9952

(3018418) pH of Serum or Plasma

695

4992

1.50

17.06

4.0

7.4

0.89

200

911

(3051593) INR in Capillary blood by Coagulation assay

6.23

17.05

5.8

13.2

—

(3012501) Base excess in Blood by calculation

370

2.60

16.43

5.4

mmol/l

1.9

2.4

1.34

228

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

686

4955

1.49

16.24

2.7

2.5

mg/l

3.2

2.8

2.37

606

4290

(3021447) Carbon dioxide [Partial pressure] in Venous blood

401

2572

1.62

16.20

6.2

8.0

kpa

5.9

5.8

1.42

393

2510

(3013650) Neutrophils [#/volume] in Blood by Automated count

1459

12112

1.42

16.20

8.6

9.9

e9/l

3.9

0.52

1267

10447

(3011648) Oxygen content in Venous blood

209

3.15

16.19

5.2

19.0

12.0

11.0

1.81

209

(3002032) Base excess in Venous blood by calculation

399

2561

1.62

16.06

6.3

8.0

mmol/l

1.5

1.4

0.04

330

2029

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

316

1935

1.68

15.25

5.9

8.6

mmol/l

24.0

23.7

0.98

306

1838

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1623

13863

1.41

14.44

7.7

7.0

u/l

89.2

88.0

0.29

1534

13049

(3013707) Erythrocyte sedimentation rate by Westergren method

1655

14187

1.41

14.40

4.4

4.1

mm/h

9.4

10.2

1.80

1559

13221

(3024354) Oxygen [Partial pressure] in Venous blood

361

2320

1.61

14.36

6.2

7.9

kpa

5.3

4.9

1.57

355

2262

(3027456) Digoxin [Moles/volume] in Serum or Plasma

211

2.92

13.49

2.7

3.1

nmol/l

0.8

0.07

165

(3010421) pH of Blood

103

450

2.29

13.48

5.4

4.8

7.4

0.18

367

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

305

1940

1.61

12.59

3.5

4.9

u/l

272.8

258.0

0.47

291

1849

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

157

832

1.90

12.33

4.9

7.2

1.3

1.2

0.10

157

826

(1616796) Gas panel - Central venous blood

395

2.30

12.12

4.1

4.4

—

(3019060) Gas panel - Arterial blood

168

922

1.84

11.84

6.6

6.0

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

529

2.10

11.76

1.9

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

370

2.29

11.27

2.8

17.1

16.9

0.22

212

(3037467) Urinalysis macro (dipstick) panel - Urine

1539

13311

1.34

10.90

4.5

4.2

—

(3002385) Erythrocyte distribution width [Ratio]

2002

18049

1.41

10.81

20.2

15.7

13.6

13.4

2.08

1979

17677

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

303

1994

1.55

10.76

1.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1144

9497

1.33

10.71

3.5

3.0

ug/l

95.5

96.2

0.04

1066

8898

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

301

1981

1.55

10.68

1.9

1.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

132

695

1.91

10.60

1.8

2.1

g/l

1.3

1.4

1.23

109

611

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

295

1942

1.55

10.45

3.0

3.2

g/l

0.2

1.35

288

1843

(3012441) Differential panel - Pleural fluid

114

3.30

10.28

1.8

1.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

289

2.37

10.02

2.4

2.2

mmol/l

1.8

1.7

0.40

283

(3030467) Casts [#/volume] in Urine by Automated count

707

5511

1.35

9.99

3.5

e6/l

0.5

0.4

0.35

557

4116

(3000850) Epithelial cells [#/volume] in Urine

543

4057

1.39

9.99

3.2

2.9

e6/l

5.4

6.4

1.12

480

3569

(3027945) Reticulocytes/100 erythrocytes in Blood

328

2243

1.49

9.71

3.6

4.4

1.8

1.6

1.57

299

2059

(3025159) Blasts/100 leukocytes in Blood

219

1374

1.61

9.52

4.2

4.8

0.1

0.3

0.53

339

(3023199) Leukocytes [#/volume] in Pleural fluid

130

3.04

9.51

2.0

1.4

e6/l

1673.1

2140.5

0.30

(3031040) Bacteria [#/volume] in Urine by Automated count

1454

12608

1.30

9.38

4.7

4.2

e6/l

425.7

1931.5

1.46

155

(3002179) Metamyelocytes/100 leukocytes in Blood

219

1390

1.59

9.08

3.9

4.4

0.7

0.6

0.56

314

(3021440) Promyelocytes/100 leukocytes in Blood

226

1447

1.58

9.03

4.2

4.7

0.2

0.1

0.40

398

(3028308) Erythrocytes [#/volume] in Pleural fluid

119

3.07

8.97

1.9

1.4

e6/l

70402.3

29081.8

0.61

(40758558) Short blood count panel - Blood

721

5718

1.33

8.88

6.2

7.7

—

(3017181) Myelocytes/100 leukocytes in Blood

235

1525

1.56

8.86

4.2

4.7

1.1

0.9

0.60

431

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

793

6380

1.31

8.81

4.0

3.7

u/l

33.0

32.0

0.15

753

6083

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1854

16687

1.33

8.74

14.5

10.7

ml/min/173m2

88.3

88.7

0.23

1568

13240

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

197

1234

1.61

8.63

3.8

3.4

pmol/l

4.8

4.7

0.12

178

1109

(3003434) Protein [Mass/volume] in Pleural fluid

138

2.87

8.60

1.8

1.4

g/l

31.4

32.5

0.24

120

(3015235) Bicarbonate [Moles/volume] in Capillary blood

104

544

1.91

8.57

5.2

6.4

mmol/l

23.4

24.2

1.45

496

(3042936) Bacteria identified in Isolate by Culture

354

2517

1.44

8.53

2.4

2.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

108

573

1.88

8.53

1.8

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

746

5976

1.31

8.48

3.9

3.6

e6/l

160.4

62.8

0.36

592

4553

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

275

1864

1.50

8.47

7.0

6.0

—

(36304419) Bacteria [Presence] in Urine

690

5480

1.32

8.32

3.5

3.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

107

571

1.87

8.31

1.8

2.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

426

2.01

8.30

1.9

2.0

—

(3026782) Osmolality of Urine

506

3842

1.36

8.26

3.3

2.9

mosm/kgh2o

553.8

560.4

0.26

455

3293

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

385

2.04

7.99

1.5

1.9

—

(3024731) MCV [Entitic volume]

2427

23013

1.84

7.96

24.8

18.2

89.5

89.3

0.96

2409

22702

(3009445) Proteinase 3 Ab [Units/volume] in Serum

135

783

1.73

7.96

1.1

1.5

—

9.1

—

(3035941) MCH [Entitic mass]

2427

23015

1.84

7.93

24.8

18.2

29.9

0.08

2409

22705

(3026361) Erythrocytes [#/volume] in Blood

2427

23018

1.84

7.88

24.9

18.2

e12/l

4.5

4.6

3.74

2373

22237

(3020630) Protein [Mass/volume] in Serum or Plasma

194

1241

1.57

7.79

2.2

2.9

g/l

65.5

66.5

0.86

178

1150

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1988

18168

1.33

7.78

5.1

4.4

mu/l

2.0

0.34

1852

16928

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

527

1.87

7.76

1.1

1.3

—

8.2

—

(3007461) Platelets [#/volume] in Blood

2425

23002

1.82

7.74

24.9

18.3

e9/l

248.3

259.5

13.87

2377

22280

(3000963) Hemoglobin [Mass/volume] in Blood

2427

23027

1.83

7.74

25.5

18.4

g/l

133.8

135.3

5.19

2411

22723

(3010813) Leukocytes [#/volume] in Blood

2427

23029

1.82

7.70

24.9

18.3

e9/l

6.8

0.50

2375

22256

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

680

5438

1.31

7.70

2.7

u/l

60.2

56.6

1.07

616

5048

(3008152) Bicarbonate [Moles/volume] in Arterial blood

150

906

1.66

7.62

9.8

7.9

mmol/l

24.7

24.5

0.43

139

849

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

275

2.20

7.55

7.8

8.0

mg/l

12.1

10.8

0.81

257

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

106

583

1.81

7.51

3.5

2.5

ug/l

691.0

403.9

0.55

100

539

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

4.10

7.48

1.4

1.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

721

5837

1.29

7.39

2.9

3.2

mmol/l

2.4

0.27

632

5187

(40761536) Microorganisms panel - Urine sediment

241

1635

1.49

7.39

3.9

3.7

—

(3018095) Leukocytes [#/volume] in Urine

859

7121

1.27

7.27

4.5

4.2

e6/l

60.5

76.3

0.52

629

4872

(3021901) Oxygen saturation in Capillary blood

360

2.01

7.18

4.0

4.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

319

2302

1.41

7.04

4.7

4.4

umol/l

8.4

7.0

0.67

280

1954

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

474

1.87

7.00

2.2

2.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

4.91

6.96

7.6

11.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

432

1.89

6.69

2.5

g/l

134.7

131.8

0.50

338

(3051651) Icteric interference index of Serum or Plasma

172

2.41

6.52

3.5

4.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

351

2612

1.37

6.42

1.8

1.7

nmol/l

1227.7

1180.4

0.40

259

1999

(3023520) Reticulocytes [#/volume] in Blood

234

1628

1.45

6.32

3.5

3.7

e9/l

75.6

68.7

1.62

163

1143

(3052851) Hemolysis interference index of Serum or Plasma

102

588

1.73

6.21

3.0

3.5

—

(3009871) Measles virus Ab [Titer] in Serum

3.14

5.91

1.5

1.9

—

(3000494) Fungus identified in Specimen by Culture

296

2172

1.38

5.90

1.7

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

2124

19784

1.32

5.90

19.0

14.1

39.5

39.9

1.21

1660

15877

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1714

15566

1.24

5.84

4.4

3.8

pmol/l

14.7

14.6

1.96

1577

14293

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

285

2.01

5.83

1.1

1.2

—

36.0

—

(3047181) Lactate [Moles/volume] in Blood

474

1.78

5.82

8.8

8.1

mmol/l

1.2

0.23

413

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

183

1235

1.48

5.79

3.1

2.6

ml/min/173m2

67.5

71.6

0.55

451

(3037522) Nuclear Ab [Titer] in Serum

364

2769

1.33

5.75

1.4

titre

510.3

518.0

0.03

532

(3040151) Glucose [Moles/volume] in Capillary blood

234

2.11

5.72

3.1

5.0

mmol/l

5.9

6.6

1.52

200

(3045788) Cell count panel - Pleural fluid

106

2.70

5.70

2.0

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

336

1.92

5.66

1.7

2.0

—

(3044009) aPTT.lupus sensitive (LA screen)

4.91

5.57

1.1

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

401

1.80

5.29

3.9

4.1

55.7

55.2

0.10

401

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

236

2.05

5.23

1.9

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

549

4468

1.26

5.14

4.9

4.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

101

613

1.64

5.13

1.4

1.8

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

364

1.82

5.05

1.5

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

287

1.93

5.04

1.9

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

600

4950

1.24

4.96

4.1

3.7

estimate

0.0

0.22

232

1723

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

241

2.01

4.96

1.3

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

513

1.68

4.95

1.4

3.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.64

4.95

1.2

1.1

80.2

89.7

0.70

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

262

1.96

4.92

1.5

—

(40768806) Pleura Pathology biopsy report

115

2.48

4.89

2.0

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

105

652

1.60

4.88

2.0

1.9

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

312

1.87

4.85

1.8

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1743

15983

1.22

4.82

5.0

4.9

mmol/mol

38.0

38.7

3.41

1634

14989

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

198

2.09

4.77

2.5

2.2

31.9

32.6

0.36

198

(3022493) Free Hemoglobin [Mass/volume] in Plasma

129

2.37

4.73

4.6

6.3

mg/l

129.3

72.1

1.33

116

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

211

1520

1.39

4.73

5.5

5.8

ng/l

73.6

72.5

0.09

184

1404

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

2.87

4.67

1.5

1.4

u/l

13.3

13.6

0.04

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

4.61

1.3

71.1

82.4

0.64

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

242

1.96

4.56

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

13.73

4.52

1.1

1.0

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

392

1.74

4.52

3.6

3.7

e9/l

4.1

4.0

0.15

392

(3004588) Protein electrophoresis panel - Serum or Plasma

136

912

1.48

4.50

1.8

2.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

515

1.64

4.40

2.4

1.9

iu/l

3.4

4.8

1.25

187

(3021960) Folate [Moles/volume] in Serum or Plasma

454

3676

1.25

4.39

1.5

nmol/l

19.8

20.5

0.52

386

3167

(3015171) Extractable nuclear Ab [Units/volume] in Serum

110

710

1.54

4.36

1.2

u/ml

3.5

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

338

1.78

4.36

1.6

—

(3039000) Anion gap in Blood

324

1.80

4.34

10.6

10.2

mmol/l

10.6

11.4

0.98

294

(3035880) pH of Pleural fluid

3.00

4.34

1.1

1.2

—

(3020891) Body temperature

618

1.57

4.31

5.5

5.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2208

20843

1.29

4.30

11.4

9.6

u/l

26.0

26.5

0.52

2152

20172

(3018572) Chloride [Moles/volume] in Blood

325

1.79

4.30

10.7

10.1

mmol/l

106.3

105.5

0.89

295

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.72

4.26

1.2

1.1

84.4

80.0

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

284

1.84

4.23

1.3

1.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

256

1.89

4.22

1.1

—

(44790048)

371

1.73

4.21

1.8

2.0

—

(44806118)

371

1.73

4.21

1.8

2.0

—

(3019174) dRVVT (LA screen)

4.46

4.17

1.1

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

309

2404

1.29

4.14

2.0

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1421

12876

1.18

4.12

3.7

3.4

u/l

45.0

42.2

0.72

1353

12190

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

441

1.66

4.10

1.7

2.6

g/l

0.4

0.9

1.54

401

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

164

2.10

4.08

1.7

2.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

240

1.89

4.00

1.0

—

(44790047)

371

1.71

3.94

1.8

2.0

—

(44790049)

371

1.71

3.94

1.8

2.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

108

711

1.51

3.94

1.3

1.6

g/l

1.1

1.2

0.57

102

677

(3023183) Ammonium ion [Moles/volume] in Plasma

562

1.57

3.92

2.6

3.4

umol/l

31.6

34.4

0.73

491

(3002256) Pathology report gross observation

278

2149

1.30

3.92

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

228

1.90

3.91

3.7

4.2

—

(3026008) Bacteria identified in Urine by Culture

621

5262

1.20

3.85

3.0

2.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

480

1.61

3.83

1.7

2.4

g/l

10.5

10.4

0.04

418

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

589

1.55

3.83

1.9

1.8

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

409

1.64

3.67

1.4

2.3

g/l

38.2

38.4

0.05

362

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

755

6536

1.19

3.66

2.0

1.9

pmol/l

96.7

96.4

0.07

429

3475

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

486

1.59

3.66

1.7

2.4

g/l

3.0

3.1

0.45

390

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

495

1.58

3.62

1.5

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

495

1.58

3.62

1.5

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

159

2.04

3.61

41.8

41.7

ug/l

7.0

6.8

0.19

145

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

592

1.52

3.54

8.5

7.0

1.8

1.6

1.73

556

(40768797) Stomach Pathology biopsy report

296

2343

1.27

3.47

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

587

1.52

3.47

8.8

7.0

0.9

0.45

553

(21494755) Public health laboratory ask at order entry panel

167

2155

0.74

3.46

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

557

1.53

3.43

1.3

2.7

mmol/l

3.6

3.5

0.29

529

(3005322) IgE [Units/volume] in Serum or Plasma

231

1775

1.30

3.42

1.2

1.4

u/ml

189.1

277.2

1.24

217

1659

(3035350) Ketones [Presence] in Urine by Test strip

1066

9530

1.16

3.41

3.8

3.4

estimate

0.0

0.50

227

1729

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

553

4683

1.20

3.41

1.6

1.7

mmol/l

1.3

1.4

0.87

458

4056

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

372

1.65

3.41

1.4

2.5

g/l

0.0

0.00

349

(3003181) Sodium [Moles/volume] in Urine

320

1.70

3.39

2.1

2.2

mmol/l

72.9

72.4

0.03

274

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

150

2.03

3.37

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

150

2.03

3.37

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

150

2.03

3.37

1.5

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

186

1391

1.33

3.35

2.2

2.3

au/ml

21.5

19.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.65

3.34

2.0

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

398

1.61

3.31

1.4

2.4

g/l

0.0

0.50

374

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

139

2.05

3.25

1.5

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

582

1.50

3.20

2.4

2.1

ug/l

2.8

1.7

0.37

516

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

319

1.67

3.17

5.0

4.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

520

1.52

3.16

1.4

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

344

2800

1.23

3.16

2.4

2.7

mmol/l

2.4

0.99

294

2439

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

411

3411

1.21

3.13

2.8

3.0

e6/l

1.0

0.02

238

1922

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

140

1016

1.37

3.09

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

492

1.53

3.07

1.3

2.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

516

1.51

3.06

1.7

2.3

g/l

3.6

3.8

0.87

382

(3021601) Nitrite [Presence] in Urine by Test strip

1062

9547

1.15

3.06

5.1

4.8

estimate

0.0

0.50

242

1784

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

1.51

3.04

1.7

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

517

1.51

3.04

1.7

2.3

g/l

6.8

7.3

1.70

402

(3042631) Mycobacterium sp identified in Specimen

178

1.88

3.00

2.4

3.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.58

3.00

2.0

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.58

3.00

2.0

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

370

1.60

3.00

1.5

2.5

g/l

0.0

0.00

348

(3009261) Glucose [Presence] in Urine by Test strip

1069

9624

1.15

3.00

3.8

3.5

estimate

0.0

0.80

234

1732

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

100

690

1.44

2.96

1.3

1.6

g/l

0.2

0.15

658

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

554

1.48

2.92

1.4

2.9

e6/l

5.9

25.2

0.98

419

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.18

2.90

1.1

miu/ml

1223.8

1653.8

1.45

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

555

1.48

2.90

1.4

2.9

e6/l

216.7

852.2

1.25

435

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

240

1897

1.26

2.88

4.5

4.0

34.4

32.1

2.68

183

1343

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

173

1311

1.31

2.88

2.0

2.4

u/l

8802.7

6626.2

0.32

483

(3037121) Protein [Mass/volume] in Urine

119

854

1.38

2.83

4.9

5.7

g/l

0.3

0.4

0.33

500

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

2.82

2.4

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.28

2.82

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.27

2.80

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.28

2.77

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.28

2.77

1.9

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.28

2.77

1.9

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.28

2.77

1.9

1.7

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

402

1.55

2.75

1.8

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.54

2.75

1.7

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

167

1269

1.31

2.74

1.3

au/ml

15.9

48.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

2.12

2.72

1.4

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

8.17

2.71

1.0

—

(3019225) pH of Specimen

195

1517

1.28

2.68

3.9

4.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

161

1222

1.31

2.67

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

401

1.53

2.57

1.1

1.3

u/ml

5.2

4.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

133

1693

0.76

2.56

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

803

7151

1.14

2.54

3.9

3.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.53

2.51

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.92

2.51

1.1

1.7

ng/l

57.0

102.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

7.00

2.51

2.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

183

1.77

2.48

1.2

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

134

1.91

2.45

1.8

1.5

25.1

35.7

0.77

(3004809) Band form neutrophils/100 leukocytes in Blood

281

1.61

2.44

2.8

3.8

1.0

1.4

0.50

229

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.29

2.42

2.4

2.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

226

1814

1.24

2.40

2.9

3.3

g/l

10.0

9.9

0.08

217

1699

(3021788) Differential panel - Synovial fluid

291

1.59

2.37

2.1

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

393

1.51

2.37

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

493

4259

1.16

2.36

3.5

3.0

umol/l

3930.2

5202.3

0.25

433

3785

(3011985) Renin [Units/volume] in Plasma

238

1.65

2.36

1.4

1.6

mu/l

49.7

94.6

0.51

212

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1876

17689

1.15

2.35

4.5

3.9

mmol/l

4.4

4.7

32.00

1776

16648

(3023511) Choriogonadotropin [Units/volume] in Urine

102

739

1.37

2.34

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

1.73

2.29

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1795

16888

1.14

2.27

4.2

3.6

mmol/l

1.2

1.3

6.63

1680

15771

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1.81

2.27

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

100

730

1.35

2.21

7.9

4.9

55.1

51.5

0.75

100

714

(3000093) Morphology [Interpretation] in Blood Narrative

205

1.68

2.21

1.1

—

(3013466) aPTT in Blood by Coagulation assay

5.44

2.17

1.0

41.7

35.8

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

507

1.42

2.17

1.2

1.3

u/ml

6.1

12.1

0.68

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

385

3284

1.17

2.17

3.2

e6/l

2.9

2.7

0.20

210

1804

(3034891) Synovial lining cells/100 cells in Synovial fluid

2.23

2.13

1.6

1.4

3.3

4.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.27

2.13

1.3

—

(40761535) Cells panel - Urine sediment

166

1307

1.26

2.12

3.4

—

(3014891) Appearance of Pleural fluid

4.20

2.11

3.7

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1859

17563

1.13

2.10

4.5

3.9

mmol/l

1.4

1.5

3.84

1750

16434

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.57

2.09

1.6

1.7

—

(3032057) Clostridioides difficile [Presence] in Stool

2.94

2.09

2.1

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

179

1.70

2.07

1.8

2.2

mg/l

35.3

27.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

507

0.61

2.06

1.0

1.1

u/ml

2.0

0.3

0.38

197

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.98

2.04

1.3

1.2

—

(4010399)

158

1244

1.26

2.03

1.5

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

169

1342

1.25

2.02

3.0

4.2

ug/l

4.9

23.5

1.99

133

1063

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

196

1.66

2.00

1.1

1.2

mg/l

24.9

35.1

2.09

156

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

116

1.86

1.98

1.2

1.1

—

38.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

586

5188

1.14

1.98

3.7

3.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

104

779

1.32

1.97

1.3

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

501

1.40

1.96

1.2

u/ml

2.1

4.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1887

17872

1.13

1.95

4.9

4.3

mmol/l

2.6

2.8

20.34

1773

16699

(40757373) Influenza virus identified in Isolate

2.76

1.94

1.6

—

(3042733) HLA Ab [Presence] in Serum

117

1.85

1.94

5.4

4.0

—

(3022145) Colonoscopy Study observation

227

1872

1.20

1.90

1.3

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

147

1.74

1.89

1.5

1.3

e6/l

62764.8

132490.5

0.40

107

(40768804) Tissue Pathology biopsy report

762

6873

1.12

1.89

2.0

—

(3020650) Glucose [Presence] in Urine

2.31

1.86

1.1

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

523

1.38

1.86

9.5

8.5

iu/ml

1226.7

339.6

0.66

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

198

1616

1.22

1.85

1.3

1.2

iu/ml

148.9

150.5

0.02

565

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.99

1.85

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

105

1.87

1.84

1.3

1.7

—

(3040893) Potassium [Moles/volume] in Capillary blood

3.12

1.83

2.9

4.2

mmol/l

4.3

4.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1820

17223

1.12

1.83

4.3

3.9

mmol/l

5.7

5.8

1.29

1666

15884

(21494814) CD8 cells/100 lymphocytes in Specimen

2.11

1.78

2.0

2.3

—

(4027681)

165

1.67

1.77

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

181

1.63

1.75

1.7

1.6

61.6

56.3

0.39

124

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

122

952

1.27

1.73

1.6

1.9

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.08

1.72

1.1

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

439

1.39

1.71

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

736

1.30

1.71

1.5

2.0

u/l

37.9

39.8

0.53

669

(3000012) Reticulocyte production index

1.92

1.69

1.8

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

160

1.66

1.69

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.61

1.67

2.3

1.6

g/l

39.0

24.8

—

(3049717) Cytology report of Urine Cyto stain

475

1.37

1.66

2.9

2.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

131

1037

1.25

1.65

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

102

1.83

1.65

1.7

5.1

umol/l

207.2

173.3

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.90

1.65

1.5

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

287

1.47

1.64

2.6

3.4

—

(3044927) Protein electrophoresis panel - Urine

139

1.70

1.63

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.25

1.62

1.9

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

648

1.31

1.61

2.0

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.87

1.60

1.5

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

352

0.61

1.54

1.2

1.4

u/ml

5.5

13.3

0.62

206

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

435

0.65

1.54

1.1

1.2

iu/ml

53.0

1172.3

—

125

(3034274) Bile acid [Moles/volume] in Serum --fasting

483

1.35

1.52

4.5

3.7

umol/l

13.4

8.9

0.56

388

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

963

0.76

1.52

1.5

1.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

293

1.44

1.50

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

3.27

1.49

1.2

1.0

mmol/l

2.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.45

1.48

1.1

—

(3011412) CD3 cells [#/volume] in Blood

335

1.41

1.47

3.2

3.3

e9/l

1.2

1.5

1.22

219

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

238

1.49

1.46

1.4

1.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

879

8088

1.10

1.43

3.0

2.6

nmol/l

75.3

74.0

0.73

793

7459

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

531

0.70

1.43

1.3

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

130

1.66

1.42

1.5

1.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

298

1.42

1.39

2.6

3.3

16.6

9.9

2.48

237

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

170

1.56

1.37

1.5

1.2

u/l

271.6

113.8

0.37

121

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.80

1.37

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

226

1.48

1.36

1.4

1.5

pmol/l

299.1

383.5

0.58

173

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

140

1.61

1.34

2.0

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.88

1.32

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

244

1.45

1.32

4.7

3.5

umol/l

1.6

1.7

0.43

239

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.86

1.31

1.7

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.86

1.31

1.7

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.86

1.31

1.7

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.96

1.30

1.6

3.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

157

1.56

1.30

1.1

—

(3025941) Bacteria identified in Stool by Culture

140

1150

1.20

1.29

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

209

1778

1.16

1.29

2.4

u/l

43.1

65.0

0.35

185

1494

(3010726) Horse dander IgE Ab [Units/volume] in Serum

841

0.77

1.29

1.1

1.2

u/ml

4.3

3.7

0.11

262

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.45

1.27

1.3

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.05

1.26

2.6

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

135

1.60

1.26

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

313

1.38

1.25

2.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

549

0.73

1.24

1.0

1.1

u/ml

8.8

8.6

0.01

284

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

121

1.62

1.21

1.0

1.1

u/l

1.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.72

1.20

1.4

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

358

3174

1.12

1.20

1.3

iu/ml

16.5

28.0

4.50

923

(3022621) pH of Urine by Test strip

100

1186

0.82

1.19

2.5

2.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

504

1.29

1.19

4.9

3.8

nmol/l

25.4

22.3

0.81

489

(3000475) Leukocytes [#/volume] in Synovial fluid

384

1.33

1.18

2.2

1.7

e6/l

11014.8

13388.8

0.28

287

(3020393) Adenovirus Ag [Presence] in Stool

169

1.51

1.18

1.4

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

588

0.74

1.17

1.1

u/ml

7.2

6.3

0.13

295

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

368

3274

1.12

1.17

1.6

pmol/l

460.9

32337486.7

3.07

288

2777

(3023419) Bacteria identified in Sputum by Culture

194

1.47

1.16

1.4

3.9

—

(3027944) Amphetamines [Presence] in Urine

123

1425

0.84

1.15

1.7

1.9

—

(3001556) Androgen free Index in Serum or Plasma

0.00

1.15

0.0

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

620

1.25

1.15

2.0

u/ml

113.8

101.3

0.62

(3008401) Mugwort IgE Ab [Units/volume] in Serum

857

0.79

1.13

1.0

1.2

u/ml

1.4

1.1

0.18

534

(3003888) Timothy IgE Ab [Units/volume] in Serum

878

0.80

1.12

1.0

1.2

u/ml

7.0

5.7

0.27

599

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.71

1.11

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

263

1.38

1.08

1.0

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

246

2148

1.13

1.08

2.7

2.4

nmol/l

353.6

354.0

0.01

230

2008

(3004451) EKG impression Narrative

1.77

1.08

1.5

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

256

1.38

1.06

1.5

1.2

—

(40768441) Liver Pathology biopsy report

174

1.47

1.05

1.5

1.6

—

(3045424) Erythrocytes [Presence] in Urine

307

1.34

1.05

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

576

1.25

1.04

1.5

1.4

ug/g

291.8

318.7

0.52

319

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.67

1.04

4.4

3.3

ug/l

67.2

117.1

1.22

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

191

1.44

1.03

1.4

1.5

—

(3033799) Differential panel - Peritoneal fluid

1.96

1.03

4.8

2.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

147

0.53

1.03

1.3

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

438

1.28

1.01

1.1

1.2

u/ml

30.7

45.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

451

4090

1.10

1.00

4.5

4.4

ug/l

1.7

2.4

2.07

382

3701

(3008898) HLA-B27 [Presence]

896

0.81

1.00

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

842

0.81

0.99

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.76

0.98

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

231

0.63

0.97

1.2

2.1

—

(4015189)

1.96

0.97

2.4

2.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

425

0.73

0.97

1.1

u/ml

1.3

4.3

2.18

168

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.63

0.96

1.3

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

523

0.76

0.95

3.4

2.2

nmol/l

0.9

0.7

0.61

445

(3016879) Cocaine [Presence] in Urine

118

1342

0.85

0.93

1.8

2.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.62

0.93

1.3

1.8

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

286

0.68

0.93

1.1

1.2

u/ml

0.3

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

127

1435

0.86

0.93

1.8

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

341

0.71

0.90

1.4

1.2

—

(1761868) Lipid panel - Serum or Plasma

712

6610

1.07

0.90

2.7

2.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.10

0.90

1.3

1.0

—

(3023410) Appearance of Cerebral spinal fluid

334

1.29

0.88

1.7

3.9

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.03

0.87

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.03

0.87

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.03

0.87

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.03

0.87

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

129

1448

0.86

0.87

1.8

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.87

0.87

1.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

473

4328

1.09

0.87

3.5

3.4

mg/l

483.9

292.8

0.35

310

2860

(3005011) Chlamydia sp Ab [Titer] in Serum

1.78

0.86

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

284

1.31

0.85

2.6

4.1

—

(3014051) Protein [Presence] in Urine by Test strip

437

0.76

0.85

2.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

676

0.81

0.85

1.8

1.6

iu/ml

2.2

0.1

—

136

(3027008) Opiates [Presence] in Urine

129

1444

0.87

0.85

1.8

2.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

102

1.54

0.83

4.5

5.2

—

(3014271) Vancomycin [Susceptibility]

1.66

0.83

2.7

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

452

1.24

0.82

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

321

1.28

0.81

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

330

1.28

0.81

2.0

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.55

0.80

2.8

3.2

mg/l

8.8

10.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

185

1.38

0.80

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

650

1.20

0.80

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

103

868

1.17

0.79

1.4

1.3

—

(40768443) Skin Pathology biopsy report

696

1.19

0.79

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.63

0.79

1.8

1.3

—

(3017569) Oxygen content in Arterial blood

1.63

0.79

1.4

2.9

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.63

0.79

1.8

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

642

1.19

0.79

1.1

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.67

0.78

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

634

1.19

0.78

1.1

1.2

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.78

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

255

1.31

0.76

1.2

—

(1002224) Polysomnography panel

772

1.17

0.76

1.0

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

282

2991

0.91

0.75

1.7

1.8

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

121

1.46

0.75

1.1

1.2

—

(3017732) Neutrophils [#/volume] in Blood

156

1361

1.13

0.75

2.4

2.6

e9/l

4.4

4.1

0.57

126

1134

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.13

0.75

2.4

10.1

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

113

1.47

0.75

1.1

1.2

iu/ml

316.7

205.8

0.66

113

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

138

1.42

0.74

2.7

4.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

362

1.25

0.73

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

237

0.70

0.73

2.6

1.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

106

1.48

0.72

8.1

8.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

304

0.74

0.72

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

390

1.23

0.71

1.2

1.3

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.57

0.70

1.0

1.1

u/ml

62.0

47.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

235

0.71

0.70

1.4

1.6

mmol/l

7.9

7.5

0.23

144

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.71

0.70

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

294

1.27

0.70

3.6

3.3

e9/l

0.3

0.2

1.68

232

(3020717) Zinc [Moles/volume] in Serum or Plasma

199

1.33

0.69

2.1

umol/l

16.0

19.6

0.57

191

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

1.88

0.69

1.2

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.88

0.69

1.6

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.57

0.69

1.7

2.5

umol/l

13.7

18.3

1.43

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.53

0.69

1.2

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.67

0.68

1.0

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

295

1.26

0.68

1.7

3.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

372

3877

0.93

0.67

2.1

2.3

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.63

0.67

1.2

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

296

1.26

0.67

3.5

3.3

e6/l

464.9

573.7

1.00

231

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

398

0.78

0.67

1.4

1.6

—

(3037756) Immunofixation for Serum or Plasma

270

1.27

0.66

1.2

1.7

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.52

0.66

1.2

1.1

—

(21494434) Karyotype in Bone marrow

198

0.69

0.66

1.2

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

167

1.35

0.66

3.9

2.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

375

0.78

0.65

1.1

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.59

0.65

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

936

0.86

0.65

1.1

1.2

u/ml

5.6

2.6

0.59

551

(3029075) Extractable nuclear Ab panel - Serum

109

1.44

0.64

1.0

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

339

3539

0.93

0.64

2.0

2.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

0.62

0.64

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

162

0.66

0.63

1.1

3.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

162

0.66

0.63

1.1

3.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

246

1.28

0.63

2.2

1.3

nmol/l

0.6

0.09

234

(3017354) Segmented neutrophils/100 leukocytes in Blood

160

1.35

0.63

2.3

3.3

59.3

54.0

0.54

108

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

203

1.30

0.62

1.5

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

852

1.14

0.62

2.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

501

4660

1.06

0.61

3.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

764

0.85

0.61

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

752

1.15

0.61

1.6

1.7

u/ml

276.3

213.3

1.15

397

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

119

1.40

0.60

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.48

0.60

1.6

2.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

763

0.86

0.60

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.60

0.0

2.4

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.60

0.0

7.4

—

131.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

970

0.87

0.59

1.5

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

535

1.17

0.59

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

302

1.23

0.58

1.1

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

760

0.86

0.58

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

154

1.34

0.58

2.1

2.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

129

1.37

0.57

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

259

1.25

0.57

1.8

1.4

—

(3045142) Bone marrow Pathology biopsy report

247

0.75

0.57

1.6

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

258

0.76

0.56

1.4

2.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

621

0.85

0.56

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

485

4522

1.06

0.56

4.3

4.1

mg/mmol

48.1

9.6

0.55

312

2963

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.45

0.56

3.5

6.4

—

(3003338) MCHC [Mass/volume]

1920

18537

1.06

0.55

20.6

16.0

g/l

333.7

333.6

0.29

1914

18383

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

197

2087

0.92

0.55

1.7

1.8

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.47

0.54

1.2

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.49

0.54

2.0

1.4

ug/l

11.5

9.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

764

0.87

0.53

1.4

—

(3028433) Virus identified in Specimen by Culture

1.41

0.53

1.2

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

105

1146

0.89

0.53

1.9

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.47

0.53

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.47

0.53

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

607

0.85

0.53

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

532

1.16

0.53

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

771

1.13

0.53

1.6

1.7

—

(3011288) Drugs identified in Urine by Screen method

969

0.88

0.52

2.3

2.8

—

(3005033) Fetal Nuchal fold Thickness US

605

0.85

0.51

1.4

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

866

1.12

0.51

4.6

3.1

e6/l

0.1

0.2

1.83

838

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

115

1.36

0.51

2.6

3.1

u/ml

860.7

1266.3

0.60

115

(3017446) Testosterone [Moles/volume] in Serum or Plasma

171

1542

1.09

0.50

2.4

2.2

nmol/l

11.5

12.0

0.25

147

1325

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

124

1.34

0.50

2.4

u/field

2.6

2.3

0.09

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

654

0.86

0.49

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

104

0.66

0.48

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

358

0.82

0.48

1.3

1.4

u/ml

1.7

3.6

0.99

224

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

108

1.36

0.47

1.1

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.46

0.46

3.6

2.1

—

(40768793) Breast Pathology biopsy report

367

0.82

0.46

1.4

1.3

—

(3022670) pH of Venous cord blood

1.44

0.46

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

258

2677

0.94

0.45

1.7

1.8

1.5

1.4

0.16

233

2389

(3029634) Reagin Ab [Titer] in Serum by VDRL

397

0.84

0.44

1.9

—

4.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

680

1.13

0.44

1.4

—

(3015183) Erythrocyte sedimentation rate

125

0.70

0.43

1.0

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

224

2331

0.93

0.43

2.0

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

148

0.73

0.43

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.42

0.42

1.3

2.2

—

(3024932) HLA-DR beta [Type]

128

1.30

0.42

1.0

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

338

3152

1.06

0.41

2.5

2.7

ug/g

145.1

106.0

0.60

264

2522

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.37

0.41

6.1

2.2

—

(3017704) Immunofixation for Urine

1.40

0.41

1.4

1.8

—

(40760409) HLA-A [Type] by High resolution

0.00

0.41

0.0

1.0

—

(4038314)

0.00

0.41

0.0

1.3

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.41

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.41

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.41

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.41

0.0

1.0

—

(36660697) Celiac disease serology panel - Serum

225

2335

0.94

0.40

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

164

1.25

0.40

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.40

0.0

5.5

—

(3024471) HLA-A [Type]

129

1.29

0.40

1.0

—

(3012565) Volume of 24 hour Urine

1.37

0.40

2.7

2.5

2147.5

2087.8

0.10

(3003327) Ova and parasites identified in Stool by Light microscopy

103

920

1.10

0.40

1.7

1.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

209

1.22

0.40

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.39

0.0

4.9

—

(3048879) Bone marrow aspiration report

1.44

0.39

2.8

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.44

0.39

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

156

1.26

0.39

1.5

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.31

0.39

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.31

0.39

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

318

1.17

0.39

1.6

1.4

u/l

16.0

19.0

0.32

272

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

165

1.25

0.39

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

130

1.28

0.38

1.0

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

139

1.27

0.38

2.5

2.6

39.6

44.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

392

1.15

0.38

2.8

3.6

mg/l

36.9

39.0

0.08

314

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.36

0.38

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

113

1.30

0.37

2.1

1.5

u/l

8.6

5.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

166

0.76

0.37

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

832

0.90

0.37

1.6

1.7

mg/l

4.6

4.4

0.04

572

(3006598) pH of Arterial cord blood

311

1.17

0.36

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

311

1.17

0.36

1.0

mmol/l

-2.2

-2.4

0.10

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

322

3014

1.05

0.36

1.3

1.2

u/ml

8.1

10.9

0.31

113

1146

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.34

0.35

3.3

4.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.63

0.35

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

630

5990

1.04

0.35

1.4

1.5

u/ml

0.9

2.4

6.86

159

1373

(3007164) IgA [Mass/volume] in Serum or Plasma

569

5400

1.04

0.35

1.5

1.6

g/l

2.0

0.01

349

3062

(3048929) Epstein Barr virus Ab [Presence] in Serum

142

1297

1.08

0.34

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

228

0.81

0.34

1.9

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

137

1250

1.08

0.34

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

140

1280

1.07

0.33

2.1

1.7

iu/l

18.8

20.7

0.33

110

969

(21494890) Protein electrophoresis panel - 24 hour Urine

133

1.25

0.33

2.3

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

846

1.09

0.33

1.4

1.3

miu/ml

190.1

231.1

0.54

418

(3021879) Hepatitis B virus core Ab [Presence] in Serum

186

1719

1.06

0.33

1.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.67

0.32

1.0

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

661

0.90

0.32

2.1

2.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

206

1.19

0.32

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

886

1.09

0.31

1.2

—

(3000330) Specific gravity of Urine by Test strip

812

0.91

0.31

4.0

3.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

182

0.81

0.31

2.2

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.32

0.30

1.1

1.5

—

(4024509)

135

1.23

0.30

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

299

1.15

0.30

1.3

1.8

—

1217.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

729

1.09

0.29

1.4

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

226

1.17

0.29

2.3

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

392

1.13

0.29

2.8

3.6

mg/l

50.8

63.8

0.31

313

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

748

1.09

0.29

1.5

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

1032

1.07

0.29

2.3

1.8

u/l

7.5

0.02

727

(3017143) Hepatitis C virus Ab [Presence] in Serum

297

2793

1.05

0.29

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

109

1.26

0.29

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.32

0.28

2.1

2.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

319

1.14

0.28

1.0

mmol/l

19.3

19.5

0.18

307

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

703

1.09

0.28

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.18

0.28

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.18

0.28

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.18

0.28

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

191

1.18

0.28

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

232

0.84

0.27

1.9

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

192

1.17

0.26

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.69

0.26

1.2

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

230

0.85

0.25

1.9

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

188

0.83

0.25

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

582

5563

1.03

0.25

3.7

3.6

mmol/l

7.5

7.9

0.92

504

4835

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

139

1.20

0.24

1.4

g/l

0.9

1.0

0.12

139

(40768446) Kidney Pathology biopsy report

139

1.20

0.24

2.1

2.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.25

0.24

1.5

1.4

nmol/l

131.0

140.5

0.27

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

612

5859

1.03

0.24

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.72

0.24

1.2

2.6

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.72

0.24

1.7

2.3

nmol/l

157.3

149.2

—

(40768800) Prostate Pathology biopsy report

228

0.86

0.23

1.2

—

(4094501)

418

1.10

0.23

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.32

0.23

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

227

0.86

0.22

1.9

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

316

1.12

0.22

1.1

iu/ml

8.0

7.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

526

5032

1.03

0.22

1.9

2.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

150

1.18

0.22

1.1

1.2

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

150

1.18

0.22

1.1

1.2

91.7

80.1

0.73

150

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

226

0.86

0.22

1.9

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

226

0.86

0.22

1.9

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

174

0.84

0.21

1.2

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

215

1.14

0.21

2.3

1.3

nmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

370

3524

1.03

0.21

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.21

0.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

121

0.81

0.21

1.0

1.1

—

(3032641) Amino acids panel - Urine

1.16

0.21

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

544

1.08

0.21

1.6

1.5

titre

64.3

81.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

421

4019

1.03

0.21

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.24

0.21

1.3

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.20

0.0

3.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

128

1314

0.95

0.20

1.4

1.3

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.20

0.0

2.0

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.20

0.0

3.3

—

142.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.20

0.0

1.8

—

2.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

8.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.20

0.0

2.9

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.20

0.0

5.9

—

(40765089) Chromosome analysis panel - Blood by G-banded

162

0.84

0.20

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

124

1.18

0.20

1.1

1.3

—

69.8

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.17

0.19

1.2

1.1

—

(3024263) Appearance of Synovial fluid

1.24

0.19

1.5

1.9

—

(4198724)

180

1.14

0.19

1.3

1.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

447

0.92

0.18

1.4

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

150

0.85

0.18

12.5

14.2

nmol/l

876.1

806.7

0.21

145

(40768795) Lymph node Pathology biopsy report

153

1.15

0.18

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

106

1088

0.95

0.18

1.8

1.6

mu/l

365.9

318.9

0.65

981

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.18

0.18

2.7

—

(3001019) Free T4 and TSH panel - Serum or Plasma

108

1107

0.95

0.17

1.7

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

275

1.10

0.17

1.2

1.4

mmol/l

6.4

7.2

0.57

197

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.22

0.17

1.9

1.6

nmol/l

26.6

17.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

1.09

0.17

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

126

1.17

0.17

1.7

2.1

—

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

191

1.13

0.17

1.2

—

(44813793)

221

0.88

0.17

1.1

—

(3049233) Organic acids panel - Urine

1.17

0.16

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

314

1.09

0.16

6.0

3.5

mmol/l

1.5

0.07

304

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.19

0.16

4.8

6.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

628

1.06

0.16

1.4

1.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.14

0.15

3.7

6.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.14

0.15

4.8

7.0

—

(40757494) Bilirubin.total [Moles/volume] in Blood

137

0.86

0.15

4.4

3.2

umol/l

58.2

144.2

—

(3006462) Nitrate [Presence] in Urine

1.11

0.15

5.4

2.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

189

1904

0.97

0.14

1.8

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

152

1537

0.97

0.14

1.4

1.5

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

156

1.13

0.14

1.1

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

288

1.09

0.14

3.1

3.9

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.19

0.14

1.2

1.5

—

10.0

—

(4034850)

530

0.94

0.14

11.7

9.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

253

2417

1.03

0.14

2.8

2.7

ug/l

0.8

0.7

0.29

153

1448

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

101

1.16

0.13

1.5

1.7

—

1428581.3

—

(3044941) Cell count panel - Synovial fluid

261

1.09

0.13

2.0

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

105

0.84

0.13

3.6

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

190

1908

0.97

0.13

1.7

1.6

—

(4062490)

271

1.08

0.12

1.2

1.4

—

(4146454)

158

1.12

0.12

2.9

2.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

246

0.91

0.12

1.2

u/ml

5.4

16.3

0.53

193

(3035933) Granulocytes/100 leukocytes in Blood

205

0.91

0.11

1.3

1.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.16

0.11

1.0

1.2

—

5.2

—

(3025130) Human papilloma virus identified in Specimen

254

0.92

0.10

1.5

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.15

0.10

1.0

—

5.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1670

16269

1.01

0.10

3.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.14

0.10

1.2

1.1

u/ml

0.8

3.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.11

0.10

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

1.09

0.09

1.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

142

0.90

0.09

1.3

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.06

0.09

1.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.04

0.09

2.6

1.8

—

(4133840)

1.04

0.09

1.4

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

400

1.05

0.09

1.7

1.5

nmol/l

0.5

0.3

0.41

325

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

133

1.10

0.08

1.0

1.5

—

(3000060) B lymphocytes [#/volume] in Blood

238

1.07

0.08

3.0

3.6

e6/l

415.0

372.3

0.15

158

(3038515) Glucose [Moles/volume] in Venous blood

286

1.06

0.08

6.3

3.4

mmol/l

6.8

7.3

0.39

278

(3045414) Leukocytes [Presence] in Urine

826

1.03

0.08

1.7

1.8

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.05

0.08

7.6

8.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

383

1.05

0.07

4.4

3.4

mg/l

29.2

23.7

0.39

240

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.84

0.07

7.3

5.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.84

0.07

3.7

2.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.83

0.07

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

364

1.05

0.07

5.6

4.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.03

0.07

1.4

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

498

0.96

0.07

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

329

0.95

0.07

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.04

0.07

1.1

1.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.04

0.07

1.2

1.3

—

74.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.87

0.06

1.4

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

408

0.96

0.06

1.5

1.4

—

(4281824)

154

1.08

0.06

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

202

1.07

0.06

1.2

1.5

—

26.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

327

3232

0.99

0.06

1.5

—

(3019150) Specific gravity of Urine by Refractometry

427

4212

0.99

0.06

4.0

3.6

kg/l

1.0

0.32

682

(3000492) Spirometry study

194

1924

0.99

0.06

1.6

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

732

0.97

0.05

1.6

1.7

—

(4035726)

152

1465

1.02

0.05

1.6

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

175

1.06

0.05

2.5

2.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

157

0.93

0.04

1.6

1.3

pmol/l

53.2

240.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

650

0.98

0.04

1.4

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

688

0.98

0.03

1.1

u/ml

0.6

7.4

2.53

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

336

3267

1.01

0.03

3.7

3.8

21.9

21.1

0.37

142

1389

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

195

0.95

0.03

1.1

1.4

u/ml

2.0

0.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

508

1.02

0.02

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

125

0.94

0.02

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

125

0.94

0.02

1.1

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

266

1.03

0.02

4.1

2.7

e6/l

757.4

747.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

501

1.02

0.01

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

212

0.97

0.01

3.4

3.9

u/ml

55.3

96.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

131

1.05

0.01

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

407

0.99

0.00

1.5

pmol/l

97.6

173.5

0.87

396

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

123

1.03

0.00

1.5

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

358

1.01

0.00

2.8

2.5

ug/min

85.5

124.2

0.29

228

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

0.99

0.00

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

403

1.00

0.00

1.3

1.7

g/l

0.7

0.8

0.44

330

(3039443) Prostate specific Ag panel - Serum or Plasma

320

1.01

0.00

1.7

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

206

1.00

0.00

1.1

1.3

—

221.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

140

1370

1.00

0.00

1.2

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

282

1.01

0.00

1.9

1.6

—

(3001729) Color of Synovial fluid

0.00

0.0

1.4

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

11.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

1266.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.01

0.00

1.0

1.7

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

30.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.89

0.00

2.3

1.7

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.0

5.6

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.1

—

(4212803)

0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

19.9

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.0

2.9

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.86

0.00

1.0

1.5

—

(3047189) Immunofixation for 24 hour Urine

0.84

0.00

2.0

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.98

0.00

1.6

3.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

4.8

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.0

—

8.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

177.9

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.6

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.3

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.0

1.3

—

1380.1

—

(4211845)

1.00

0.00

5.4

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_SEPTA_DEFEC and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_SEPTA_DEFEC	1.871 [1.6, 2.18]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.008

During the follow-up period (1.1.1998 — 31.12.2019), 678 out of 17245 females with Q17_SEPTA_DEFEC died.

Males

Parameter	HR [95% CI]	p-value
Q17_SEPTA_DEFEC	1.71 [1.44, 2.03]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 575 out of 15035 males with Q17_SEPTA_DEFEC died.

Mortality risk

Mortality risk for people of age

years, who have Q17_SEPTA_DEFEC.

N-year risk	Females	Males
1	0.134%	0.217%
5	0.916%	1.639%
10	2.426%	4.085%
15	4.574%	7.915%
20	7.682%	12.977%

Relationships between endpoints

↥

Index endpoint: Q17_SEPTA_DEFEC – Septal defects

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Septal defects

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints